ABIO

ARCA biopharma, Inc.

1.63 USD
-0.04 (-2.40%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

ARCA biopharma, Inc. stock is down -0.61% since 30 days ago. The next earnings date is Apr 22, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 30.77% of the previous 26 March’s closed higher than February.

About ARCA biopharma, Inc.

ARCA biopharma, Inc. develops and commercializes genetically targeted therapies for cardiovascular diseases. The company was incorporated in 2004 and is headquartered in Westminster, Colorado. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 and Gencaro.